Are We There Yet? The Clinical Potential of Intranasal Oxytocin in Psychiatry
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
The hormone oxytocin plays a major role in relationship formation and social functioning in animals and humans. We review theory and research examining the potential for intra-nasal oxytocin as an adjunctive medication for several mental health problems and risks: autism, schizophrenia, developmental precursors of psychopathy, social phobia, anorexia nervosa, obsessive compulsive disorder, depression (especially postnatal) and impaired maternal-infant bonding. Initial findings suggest that oxytocin administration may alleviate symptoms of autism and social phobia, but current evidence is insufficient to recommend oxytocin as a standard treatment. Despite reasonable theoretical indications, there has also been no systematic examination of oxytocin effects with psychopathy, anorexia, depression, or in mothers with problems bonding with their infants. Findings in patients with obsessive compulsive disorder suggest that oxytocin administration may not be beneficial in this group. Overall, there are good reasons to suggest that intra-nasal oxytocin may be a promising adjunctive treatment for specific mental health problems that involve impairments in engaging comfortably with other people; however, research is in its infancy; the specificity and durability of effects remain unknown, and issues of safety and modes of delivery have yet to be addressed. Keywords: Oxytocin, Anorexia, Autism, Depression, Maternal-infant bonding, Obsessive compulsive disorder, Psychopathy, Schizophrenia, Social phobia, hallucinations
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Less is more: meta-analyses of sensitivity and attachment interventions in early childhood
Bakermans-Kranenburg, M. J., van IJzendoorn, M. H., & Juffer, F. (2003) · Psychological Bulletin · doi:10.1037/0033-2909.129.2.195 · Cited by 1,883
The outcome of anorexia nervosa in the 20th century
Steinhausen, H.-C. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1284 · Cited by 1,761 · cited 1×
“up, and there is a 20% rate of non-responding to treatment [67].”
BackgroundOxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639
Social effects of oxytocin in humans: context and person matter
Bartz, J. A., Zaki, J., Bolger, N., & Ochsner, K. N. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.05.002 · Cited by 1,581 · cited 1×
“Aside from the disorders discussed within the current review, intranasal oxytocin is being explored as a potential therapeutic agent for trichotillomania, post-traumatic stress-disorder, and borderline personality disorder [111].”
BackgroundRisperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574 · cited 1×
“, for risperidone [37]).”
Oxytocin shapes the neural circuitry of trust and trust adaptation in humans
Baumgartner, T., Heinrichs, M., Vonlanthen, A., Fischbacher, U., & Fehr, E. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.009 · Cited by 1,258 · cited 1×
“For example, oxytocin could encourage social approach to strangers by: decreasing amygdala activation and the stress response associated with social threat [9-12], increasing accuracy in reading others’ emotions [13], increasing eye-contact [14], and increasing trust and cooperative behaviours [15, 16].”
BackgroundPromoting social behavior with oxytocin in high-functioning autism spectrum disorders.
Andari, E., Duhamel, J.-R., Zalla, T., Herbrecht, E., Leboyer, M., & Sirigu, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910249107 · Cited by 941
Oxytocin increases generosity in humans
Zak, P. J., Stanton, A. A., & Ahmadi, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001128 · Cited by 831
Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala
Huber, D., Veinante, P., & Stoop, R. (2005) · Science · doi:10.1126/science.1105636 · Cited by 804 · cited 1×
“For example, oxytocin could encourage social approach to strangers by: decreasing amygdala activation and the stress response associated with social threat [9-12], increasing accuracy in reading others’ emotions [13], increasing eye-contact [14], and increasing trust and cooperative behaviours [15, 16].”
Background
Cited by
Does Oxytocin Increase Trust in Humans? A Critical Review of Research
Nave, G., Camerer, C., & McCullough, M. (2015) · Perspectives on Psychological Science · doi:10.1177/1745691615600138 · Cited by 316
Dadds, M. R., Moul, C., Cauchi, A., Dobson-Stone, C., Hawes, D. J., Brennan, J., & Ebstein, R. E. (2014) · Development and Psychopathology · doi:10.1017/s0954579413000497 · Cited by 230
Groppe, S. E., Gossen, A., Rademacher, L., Hahn, A., Westphal, L., Gründer, G., & Spreckelmeyer, K. N. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.023 · Cited by 218
Pharmacological therapies for autism spectrum disorder: a review.
(2015) · PubMed Central · Cited by 150
Zanos, P., Georgiou, P., Wright, S. R., Hourani, S. M., Kitchen, I., Winsky-Sommerer, R., & Bailey, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.285 · Cited by 133
“In particular, OT promotes social bonding as well as social memory (Keverne and Curley, 2004) and exerts a potent anxiolytic, anti-aggressive and antidepressant effect in humans (Heinrichs and Domes, 2008; Liu et al, 2012), and in animal models (Neumann et al, 2012).”
Background
Metadata
- Authors
- C. J. Liu, J., A. McErlean, R., & R. Dadds, M.
- Venue
- Current Psychiatry Reviews
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2012-02-01
- Volume
- 8
- Issue
- 1
- Pages
- 37-48
- ISSN
- 1573-4005 (ISSN-L)
- OpenAlex
- W2170831410
- Cited by
- 24
- References
- 52
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are We There Yet? The Clinical Potential of Intranasal Oxytocin in Psychiatry. https://app.cochat.ai/papers/10.2174/157340012798994902
- The paper
- C. J. Liu, J., A. McErlean, R., & R. Dadds, M. (2012). Are We There Yet? The Clinical Potential of Intranasal Oxytocin in Psychiatry. Current Psychiatry Reviews. https://doi.org/10.2174/157340012798994902
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.